Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2012

Total Assets: $14.9M

Liabilities Breakdown FY2012

Total Liabilities: $5.4M